$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Microglia are the dominant resident innate immune cells in the brain and account for 10-15% of cells in the adult brain1,2. They use their receptor repertoire to dynamically monitor the brain microenvironment and regulate the normal brain function to maintain brain homeostasis3. Microglia are very sensitive to the changes in their microenvironment and undergo changes in cell morphology, immunophenotype, and function with pathological conditions or various stimulations. Microglial activation states are influenced by the cellular energy demands required for their function, such as phagocytosis, cytokine production, or tissue repair. Therefore, cellular energy metabolism plays a crucial role in regulating changes in microglial function4. Microglial dysregulation leads to excessive release of pro-inflammatory cytokines (e.g., IL-1β, TNF-α) and reactive oxygen species (ROS), predisposing the brain to neuroinflammation5,6. Chronic microglial dysregulation and the resulting neuroinflammatory environment lays a foundation for neurodegeneration7.
The brain accounts for only 2% of body weight but 20% of the body's total energy consumption. Mitochondria are the primary source of energy in brain cells and act as key players in the pathogenesis of both acute and chronic brain disorders8. Previous studies have established a strong correlation between microglial activation and metabolic dysfunction in aging9 and age-related disorders such as Alzheimer's disease10,11, highlighting the pivotal role of mitochondria in cellular senescence and neurodegeneration. Impaired mitochondrial function leads to diminished energy production, elevated oxidative stress, and increased neuroinflammation during aging and age-related diseases.
While extensive research has elucidated the role of mitochondria in energy metabolism, aging, and brain disorders, the role of common post-translational modifications, such as glycosylation, in mitochondrial biology and function remains insufficiently explored. Glycosylation, the enzymatic addition of sugar moieties called glycans to proteins by glycosylation enzymes, is the most common post-translational modification in most brain cells, including microglia. Activated microglia modulate their immune function under inflammatory stimuli by regulating the intracellular or cell surface glycan expression12. The pro- and anti-inflammatory responses exhibited by microglia post-stimulation are also regulated by the glycans13. Mitochondrial proteins also have these glycan modifications, which regulate their function and localization. However, detailed analysis of the cell-specific mitochondrial glycosylation patterns in the microglia is lacking due to the technical challenges in investigating sub-cellular glycosylation. Despite the well-characterized roles of glycosylation in modulating the microglial phenotype, the role of glycans in modulating mitochondrial function and subsequently, cellular immunophenotype in microglia remains poorly understood.
Limited studies investigating mitochondrial protein glycosylation have focused primarily on lectin-based identification of glycosylation patterns. Lectins are glycan-binding proteins that bind biomolecular glycan moieties14,15, which lack the specificity and ability to provide detailed information about the glycan composition. Mass spectrometric modalities offer a detailed identification of the glycan compositions to overcome the analytical challenges presented by lectin analysis. One such modality, infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI), employs a hybrid ionization strategy, using a mid-IR laser to resonantly excite water found in biological specimens16 to desorb the neutral species and subject them to an orthogonal electrospray plume, followed by analysis using a high-resolution accurate mass Orbitrap mass spectrometer. IR-MALDESI has been previously demonstrated for the direct analysis of tissue metabolites17, with distinct advantages of rapid analysis18, soft ionization method, and the predictability of sialic acid content of N-linked glycans based on the isotopic distribution patterns of chlorinated glycan adducts19. However, the adaptation of this platform for the direct analysis of sub-cellular glycans has not been demonstrated.
Here, we report a high-throughput protocol for mitochondrial isolation from microglial cells, isolation of mitochondrial N-glycans, and mitochondrial N-glycan detection and analysis using IR-MALDESI mass spectrometry. This protocol will be foundational in uncovering novel insights into the role of glycosylation in mitochondrial function, potentially identifying new therapeutic targets for neuroinflammatory and neurodegenerative disorders.